Overview
Karol Sanchez-Carrillo practices in Mexico City, Mexico. Sanchez-Carrillo is rated as a Distinguished expert by MediFind in the treatment of ALG1-CDG. Their top areas of expertise are ALG1-CDG, PMM2-Congenital Disorder of Glycosylation, Dihydrolipoamide Dehydrogenase Deficiency, and Maple Syrup Urine Disease.
Their clinical research consists of co-authoring 28 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of ALG1-CDG.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALG1-CDGSanchez-Carrillo isDistinguished. Learn about ALG1-CDG.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Sanchez-Carrillo isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Childhood Acute Myeloid LeukemiaSanchez-Carrillo isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Collins Pope SyndromeSanchez-Carrillo isExperienced. Learn about Collins Pope Syndrome.
- Dihydrolipoamide Dehydrogenase DeficiencySanchez-Carrillo isExperienced. Learn about Dihydrolipoamide Dehydrogenase Deficiency.
- Heart TumorSanchez-Carrillo isExperienced. Learn about Heart Tumor.
- Infantile NeutropeniaSanchez-Carrillo isExperienced. Learn about Infantile Neutropenia.